There are no breaking news at the moment

Post Tagged with: "EUA"

FDA Authorizes First Oral Antiviral for Treatment of COVID-19

FDA Authorizes First Oral Antiviral for Treatment of COVID-19

  Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for Pfizer’s Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the treatment of mild-to-moderate coronavirus disease (COVID-19) in adults and pediatric patients (12 years of age and older weighing at least 40 kilograms or about 88 pounds) with positive results of direct SARS-CoV-2 testing, and[Read More…]

by December 22, 2021 0 comments Covid / CDC / FDA
Coronavirus (COVID-19) Update: FDA Authorizes Additional Vaccine Dose for Certain Immunocompromised Individuals

Coronavirus (COVID-19) Update: FDA Authorizes Additional Vaccine Dose for Certain Immunocompromised Individuals

  Other fully vaccinated individuals do not need an additional vaccine dose right now Today, the U.S. Food and Drug Administration amended the emergency use authorizations (EUAs) for both the Pfizer-BioNTech COVID-19 Vaccine and the Moderna COVID-19 Vaccine to allow for the use of an additional dose in certain immunocompromised individuals, specifically, solid organ transplant recipients or those who are[Read More…]

by August 13, 2021 1 comment Covid / CDC / FDA